文献速递神经肿瘤

REST-DRD2机制影响胶质母细胞瘤干细胞介导的肿瘤发生

REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
PubMed 文献 · Neuro Oncol · 2019-01-01

本研究探讨REST如何调控胶质母细胞瘤干细胞(GSC)的致瘤潜力,发现DRD2是REST的直接靶基因,REST通过DRD2影响肿瘤侵袭和凋亡。TCGA数据支持REST-DRD2轴的存在,并揭示高REST/低DRD2(HRLD)和低REST/高DRD2(LRHD)为两种分子不同的GBM亚型。

要点

  • REST直接靶向DRD2,DRD2是REST下游调控肿瘤发生的关键因子。
  • REST-DRD2轴调控GSC的侵袭和凋亡过程。
  • HRLD和LRHD肿瘤是不同于已知GBM亚型的特定功能亚群。

核心结论

  • REST通过DRD2调控神经递质信号通路影响高REST胶质瘤干细胞的致瘤性。
  • REST-DRD2机制形成具有不同基因富集模式的特定GBM亚型。

研究设计与样本

  • 使用2个独立的高REST(HR)GSC系进行全基因组分析、生化验证、基因敲低实验和小鼠肿瘤模型。
  • 分析内部患者肿瘤样本及TCGA数据库中的患者数据。

主要发现

  • 全基因组转录组和DNA结合分析提示DRD2是REST的直接靶标。
  • 敲低REST及双敲低REST和DRD2的小鼠颅内肿瘤模型验证了该靶向关系。
  • DRD2作为REST下游靶点,至少部分通过控制侵袭和凋亡调控肿瘤发生。
  • TCGA GBM数据支持REST-DRD2轴的存在,并揭示HRLD和LRHD肿瘤为特定亚型,分子上不同于已知GBM亚型。
  • 内部GBM肿瘤中也可见HRLD/LRHD反向表达模式。

临床怎么用

  • REST-DRD2轴可能作为GBM分子分型的补充依据。
  • DRD2可能成为高REST胶质瘤干细胞靶向治疗的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is a lethal, heterogeneous human brain tumor, with regulatory mechanisms that have yet to be fully characterized. Previous studies have indicated that the transcriptional repressor REST (repressor element-1 silencing transcription factor) regulates the oncogenic potential of GBM stem cells (GSCs) based on level of expression. However, how REST performs its regulatory role is not well understood. METHODS: We examined 2 independent high REST (HR) GSC lines using genome-wide assays, biochemical validations, gene knockdown analysis, and mouse tumor models. We analyzed in-house patient tumors and patient data present in The Cancer Genome Atlas (TCGA). RESULTS: Genome-wide transcriptome and DNA-binding analyses suggested the dopamine receptor D2 (DRD2) gene, a dominant regulator of neurotransmitter signaling, as a direct target of REST. Biochemical analyses and mouse intracranial tumor models using knockdown of REST and double knockdown of REST and DRD2 validated this target and suggested that DRD2 is a downstream target of REST regulating tumorigenesis, at least in part, through controlling invasion and apoptosis. Further, TCGA GBM data support the presence of the REST-DRD2 axis and reveal that high REST/low DRD2 (HRLD) and low REST/high DRD2 (LRHD) tumors are specific subtypes, are molecularly different from the known GBM subtypes, and represent functional groups with distinctive patterns of enrichment of gene sets and biological pathways. The inverse HRLD/LRHD expression pattern is also seen in in-house GBM tumors. CONCLUSIONS: These findings suggest that REST regulates neurotransmitter signaling pathways through DRD2 in HR-GSCs to impact tumorigenesis. They further suggest that the REST-DRD2 mechanism forms distinct subtypes of GBM.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Marisetty AL, Lu L, Veo BL, et al. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019. PMID: 30953587. doi:10.1093/neuonc/noz030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。